| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial resistance surveillance: China's nearly 40-year effort
|
Ding, Li
|
|
|
62 |
2 |
p.
|
artikel
|
| 2 |
Application of new indicators to assess the quality of antimicrobial use in intensive care units
|
Rodríguez-Campos, Eder
|
|
|
62 |
2 |
p.
|
artikel
|
| 3 |
A real-world observational retrospective cohort study of Canadian people living with HIV switching from nevirapine plus two nucleoside reverse transcriptase inhibitors to dolutegravir/lamivudine
|
de Wet, Joseph J.
|
|
|
62 |
2 |
p.
|
artikel
|
| 4 |
Characterisation of carbapenemase-producing Acinetobacter baumannii isolates from danish patients 2014–2021: detection of a new international clone – IC11
|
Hansen, Frank
|
|
|
62 |
2 |
p.
|
artikel
|
| 5 |
Clinical outcomes and safety of intravenous polymyxin B-based treatment in critically ill patients with carbapenem-resistant Acinetobacter baumannii nosocomial pneumonia
|
Qiao, Luyao
|
|
|
62 |
2 |
p.
|
artikel
|
| 6 |
Clinical results with the use of ceftaroline and ceftobiprole: real-life experience in a tertiary care hospital
|
Zampino, Rosa
|
|
|
62 |
2 |
p.
|
artikel
|
| 7 |
Comment on ‘Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial’
|
Gautier-Veyret, Elodie
|
|
|
62 |
2 |
p.
|
artikel
|
| 8 |
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: a systematic review and meta-analysis of randomized controlled trials
|
Chen, Tim Yi-Ting
|
|
|
62 |
2 |
p.
|
artikel
|
| 9 |
Comparison of dosing strategies in obese patients prescribed intravenous acyclovir and evaluation of rate of acute kidney injury
|
Zelnicek, Taylor D.
|
|
|
62 |
2 |
p.
|
artikel
|
| 10 |
Concentration of contezolid in cerebrospinal fluid and serum in a patient with tuberculous meningoencephalitis: A case report
|
Guo, Wanru
|
|
|
62 |
2 |
p.
|
artikel
|
| 11 |
Corrigendum to ‘The battle against fungi lessons in antifungal stewardship from COVID 19 times’ [International Journal of Antimicrobial Agents Volume 62/1 (2023) 106846]
|
Kanj, Souha S.
|
|
|
62 |
2 |
p.
|
artikel
|
| 12 |
CRO infection and the Use of MRSA-active Medication for Prophylaxis affect the Prognosis of Patients with Hematological Malignancies after CAR-T Infusion
|
Yang, Jian
|
|
|
62 |
2 |
p.
|
artikel
|
| 13 |
Dose optimisation of linezolid in critically ill patients based on a population pharmacokinetic model: A two-centre prospective interventional study
|
Shi, Lu
|
|
|
62 |
2 |
p.
|
artikel
|
| 14 |
Efficacy and Safety of Molnupiravir Treatment for COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Tian, Fangyuan
|
|
|
62 |
2 |
p.
|
artikel
|
| 15 |
Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm
|
Benavent, Eva
|
|
|
62 |
2 |
p.
|
artikel
|
| 16 |
Evaluation of tetracycline and fluoroquinolone therapy against Japanese spotted fever: Analysis based on individual data from case reports and case series
|
Itoh, Kazuhiro
|
|
|
62 |
2 |
p.
|
artikel
|
| 17 |
Exogenous nitric oxide generated from SNAP blocks porcine circovirus type 2 replication and regulates NF-κB activity in PK-15 cells
|
Liu, Chuanmin
|
|
|
62 |
2 |
p.
|
artikel
|
| 18 |
Exploration of the optimal GS-441524 trough concentration for treating COVID-19
|
Nakano, Yuki
|
|
|
62 |
2 |
p.
|
artikel
|
| 19 |
Factors associated with meropenem pharmacokinetic/pharmacodynamic target attainment in septic critically ill patients treated with extended intermittent infusion or continuous infusion
|
Tournayre, Sarah
|
|
|
62 |
2 |
p.
|
artikel
|
| 20 |
Functional characterization and clinical implication of a novel epidemic carbapenem-resistant Acinetobacter baumannii genetic marker
|
Chen, Chyi-Liang
|
|
|
62 |
2 |
p.
|
artikel
|
| 21 |
Impact of a newly established expert clinical pharmacological advice programme based on therapeutic drug monitoring results in tailoring antimicrobial therapy hospital-wide in a tertiary university hospital: Findings after the first year of implementation
|
Cojutti, Pier Giorgio
|
|
|
62 |
2 |
p.
|
artikel
|
| 22 |
In reply to comment on ‘Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicenter, prospective, cluster randomised, crossover clinical trial’
|
Veringa, Anette
|
|
|
62 |
2 |
p.
|
artikel
|
| 23 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
62 |
2 |
p.
|
artikel
|
| 24 |
In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012–2021
|
Lee, Yu-Lin
|
|
|
62 |
2 |
p.
|
artikel
|
| 25 |
In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial
|
Stewart, Adam G.
|
|
|
62 |
2 |
p.
|
artikel
|
| 26 |
In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020
|
Lee, Yu-Lin
|
|
|
62 |
2 |
p.
|
artikel
|
| 27 |
Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants
|
Allaw, Fatima
|
|
|
62 |
2 |
p.
|
artikel
|
| 28 |
Mechanisms of ceftazidime/avibactam resistance in drug-naïve bacteraemic Enterobacterales strains without metallo-beta-lactamase production: Associated with ceftazidime impedance
|
Xiong, Luying
|
|
|
62 |
2 |
p.
|
artikel
|
| 29 |
One Health and Global Health View of Antimicrobial Susceptibility through the “Eye” of Aeromonas: Systematic Review and Meta-Analysis
|
Jones, Daniel Christopher
|
|
|
62 |
2 |
p.
|
artikel
|
| 30 |
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections
|
Goulenok, T.
|
|
|
62 |
2 |
p.
|
artikel
|
| 31 |
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
|
Gatti, Milo
|
|
|
62 |
2 |
p.
|
artikel
|
| 32 |
Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China
|
Hu, Huangdu
|
|
|
62 |
2 |
p.
|
artikel
|
| 33 |
Prevalence of inappropriate use of nirmatrelvir-ritonavir antiviral therapy in hospitalized patients: A multi-centre retrospective study in China
|
Shi, Changcheng
|
|
|
62 |
2 |
p.
|
artikel
|
| 34 |
Prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: Review of the evidence
|
Kollef, Marin
|
|
|
62 |
2 |
p.
|
artikel
|
| 35 |
Real-world effectiveness of ceftazidime/avibactam versus polymyxin B in treating patients with carbapenem-resistant Gram-negative bacterial infections
|
Qu, Junyan
|
|
|
62 |
2 |
p.
|
artikel
|
| 36 |
Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort
|
Hung, Tran Minh
|
|
|
62 |
2 |
p.
|
artikel
|
| 37 |
Streptococcus mutans sigX-inducing peptide inhibits the virulence of Candida albicans and oral candidiasis through the Ras1-cAMP-Efg1 pathway
|
Zhang, Kaiwen
|
|
|
62 |
2 |
p.
|
artikel
|
| 38 |
Title Page & Editorial Board
|
|
|
|
62 |
2 |
p.
|
artikel
|
| 39 |
Treatment success of rescue regimens after dual therapy failure in people living with HIV in a real-life setting
|
Clemente, Tommaso
|
|
|
62 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving